4CMenB (Bexsero®) vaccine

BIOLOGICAL2 trials

Sponsors

Ospedale Policlinico San Martino, University of Oxford

Conditions

Acquired ImmunodeficiencyGonorrhea

Unknown Phase

Safety, Tolerability and Immunogenicity of 4CMenB Vaccine(2 Doses) in Adults With an Immunodeficiency

CompletedNCT04295733

Ospedale Policlinico San MartinoAcquired Immunodeficiency

Start: 2020-02-06End: 2024-01-11Updated: 2024-01-22

Gonococcal Vaccine Study in Key Populations in Kenya

CompletedNCT04297436

University of OxfordGonorrhea

Start: 2021-05-31End: 2022-02-28Updated: 2022-04-14

Related Papers

Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population.

2024-08-0710 citations